MySugr

MySugr is the Austrian company developing mobile application for patients with diabetes. The program which is available in 53 countries in 13 languages allows to trace sugar level in blood, recommends medicines and measures of treatment. By the end of June, 2017 more than 1 million people use MySugr service worldwide, and the staff of the company totals 47 employees.

2017: Roche buys MySugr

On June 30, 2017 the Swiss pharmaceutical company Roche announced purchase of MySugr for expansion of digital business. The cost of the transaction does not reveal.

As noted in Roche, acquisition of MySugr will allow the company to increase business volume in the field of productions of diagnostic aids of diabetes. In this market Roche faced strong price pressure that led to decrease in growth rates of sales of products and emergence of rumors about an asset sale. Roche said that the diabetic division will not be sold, it it is going to develop and expand.

Roche buys the platform for control of diabetes for development of digital business

These investments reflect our commitment to treatment of diabetes and to improvement of life of people, patients with it — the representative of Roche told Reuters news agency.

According to the head of diagnostic business of Roche Roland Diggelmann (Roland Diggelmann), the company as a result of acquisition of MySugr will be able to propose the available easily integrated solutions on the open platform which will help "better to react to unsatisfied needs of people with diabetes".

Thanks to experience in treatment of diabetes and a global network which Roche has the mySugr service will become "the irreplaceable assistant" for people with this disease, the cofounder of mySugr Frank Westermann noted.

Roche promises that after the transaction the MySugr application will continue work with devices of other producers.^[1]

Notes